Holen Sie sich die Stockscreener-App
58.01
4.43%
2.46
Handel nachbörslich:
58.01
Schlusskurs vom Vortag:
$55.55
Offen:
$55.65
24-Stunden-Volumen:
1.90M
Relative Volume:
1.61
Marktkapitalisierung:
$4.61B
Einnahmen:
$900.66M
Nettoeinkommen (Verlust:
$-453.20M
KGV:
-9.766
EPS:
-5.94
Netto-Cashflow:
$-274.19M
1W Leistung:
+16.51%
1M Leistung:
+11.02%
6M Leistung:
+11.99%
1J Leistung:
+72.70%
1-Tages-Spanne:
$55.14
$58.05
1-Wochen-Bereich:
$48.95
$58.05
52-Wochen-Spanne:
$30.41
$58.38
Ptc Therapeutics Inc Stock (PTCT) Company Profile
Firmenname
Ptc Therapeutics Inc
Sektor
Branche
Telefon
(908) 222-7000
Adresse
500 WARREN CORPORATE CENTER DRIVE, WARREN, NJ
Vergleichen Sie PTCT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PTCT
Ptc Therapeutics Inc
|
58.01 | 4.16B | 900.66M | -453.20M | -274.19M | -5.94 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Ptc Therapeutics Inc Stock (PTCT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-17 | Eingeleitet | Truist | Buy |
| 2025-05-09 | Hochstufung | BofA Securities | Neutral → Buy |
| 2025-05-07 | Hochstufung | Citigroup | Sell → Neutral |
| 2025-03-11 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2025-03-07 | Eingeleitet | Scotiabank | Sector Perform |
| 2024-12-13 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-12-03 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-10-10 | Fortgesetzt | Raymond James | Mkt Perform |
| 2024-09-04 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-08-26 | Fortgesetzt | UBS | Buy |
| 2024-05-20 | Hochstufung | Raymond James | Underperform → Mkt Perform |
| 2023-12-19 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2023-12-08 | Eingeleitet | Wells Fargo | Overweight |
| 2023-10-30 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2023-10-27 | Herabstufung | Citigroup | Neutral → Sell |
| 2023-10-06 | Herabstufung | Truist | Buy → Hold |
| 2023-09-18 | Herabstufung | Citigroup | Buy → Neutral |
| 2023-09-15 | Herabstufung | Raymond James | Outperform → Underperform |
| 2023-03-17 | Eingeleitet | SVB Securities | Market Perform |
| 2022-12-14 | Eingeleitet | Goldman | Sell |
| 2022-09-12 | Eingeleitet | Jefferies | Buy |
| 2022-09-09 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2022-09-01 | Eingeleitet | Citigroup | Buy |
| 2022-04-04 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2021-10-18 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2021-04-26 | Fortgesetzt | Credit Suisse | Neutral |
| 2021-03-29 | Hochstufung | RBC Capital Mkts | Underperform → Sector Perform |
| 2021-02-12 | Herabstufung | BofA Securities | Buy → Neutral |
| 2021-01-05 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-11-30 | Herabstufung | RBC Capital Mkts | Sector Perform → Underperform |
| 2020-10-30 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-10-28 | Eingeleitet | UBS | Neutral |
| 2020-10-07 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-08-25 | Eingeleitet | Raymond James | Outperform |
| 2020-04-09 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-02-20 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-02-20 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2019-11-12 | Eingeleitet | SunTrust | Buy |
| 2019-05-13 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-04-11 | Eingeleitet | Bernstein | Outperform |
| 2018-10-03 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2018-10-01 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2018-07-19 | Eingeleitet | Credit Suisse | Outperform |
| 2018-06-18 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2018-04-04 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2018-01-29 | Fortgesetzt | RBC Capital Mkts | Sector Perform |
| 2017-11-16 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2017-10-26 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2017-10-09 | Herabstufung | JP Morgan | Neutral → Underweight |
Alle ansehen
Ptc Therapeutics Inc Aktie (PTCT) Neueste Nachrichten
Heatmap analysis for PTC Therapeutics Inc. and competitorsMarket Sentiment Summary & AI Based Trade Execution Alerts - Newser
Rafferty Asset Management LLC Sells 20,965 Shares of PTC Therapeutics, Inc. $PTCT - MarketBeat
PTC Therapeutics (NASDAQ:PTCT) Director Sells $83,600.05 in Stock - MarketBeat
Russell Investments Group Ltd. Cuts Position in PTC Therapeutics, Inc. $PTCT - MarketBeat
Palo Alto Investors LP Grows Stock Position in PTC Therapeutics, Inc. $PTCT - MarketBeat
PTC Therapeutics (NASDAQ:PTCT) Stock Price Up 6.1%Should You Buy? - MarketBeat
Key metrics from PTC Therapeutics Inc.’s quarterly data2025 Retail Activity & Verified Entry Point Signals - Newser
MPM Bioimpact LLC Has $22.42 Million Holdings in PTC Therapeutics, Inc. $PTCT - MarketBeat
What to expect from PTC Therapeutics Inc. in the next 30 days2025 Top Decliners & Short-Term Swing Trade Alerts - Newser
How to interpret RSI for PTC Therapeutics Inc. stockJuly 2025 Big Picture & Community Consensus Trade Signals - Newser
How to use a screener to detect PTC Therapeutics Inc. breakoutsMarket Movement Recap & Free Weekly Watchlist of Top Performers - Newser
Comparing PTC Therapeutics Inc. in custom built stock radarsInsider Selling & Precise Buy Zone Tips - Newser
Multi asset correlation models including PTC Therapeutics Inc.Trade Analysis Report & Daily Risk Controlled Trade Plans - Newser
Will PTC Therapeutics Inc. price bounce be sustainableOptions Play & Weekly Return Optimization Plans - Newser
Is now a turning point for PTC Therapeutics Inc.July 2025 Earnings & Fast Entry and Exit Trade Plans - Newser
Using Bollinger Bands to evaluate PTC Therapeutics Inc.July 2025 Pullbacks & Short-Term Swing Trade Alerts - Newser
What earnings revisions data tells us about PTC Therapeutics Inc.Weekly Stock Analysis & Weekly Setup with High ROI Potential - Newser
PTC Therapeutics, Inc. $PTCT Shares Bought by Driehaus Capital Management LLC - MarketBeat
PTC Therapeutics: A Convergence of Strength in RS Rating, Catalysts, and Institutional Sentiment - AInvest
Combining price and volume data for PTC Therapeutics Inc.Dollar Strength & Community Driven Trade Alerts - Newser
Institutional scanner results for PTC Therapeutics Inc.July 2025 Closing Moves & AI Forecasted Stock Moves - Newser
Northern Trust Corp Increases Position in PTC Therapeutics, Inc. $PTCT - MarketBeat
Is PTC Therapeutics Inc. stock a good pick for beginnersJuly 2025 Fed Impact & Capital Protection Trade Alerts - khodrobank.com
Real time scanner hits for PTC Therapeutics Inc. explainedEarnings Beat & Risk Controlled Stock Alerts - Newser
RareMed Expands Partnership with PTC Therapeutics to Enhance Access to Sephience Therapy for PKU Patients - AInvest
Using economic indicators to assess PTC Therapeutics Inc. potentialJuly 2025 Weekly Recap & Weekly Momentum Picks - Newser
Technical analysis overview for PTC Therapeutics Inc. stockJuly 2025 Breakouts & AI Powered Market Trend Analysis - Newser
Best data tools to analyze PTC Therapeutics Inc. stock2025 Top Decliners & AI Based Buy and Sell Signals - Newser
Ieq Capital LLC Buys 38,804 Shares of PTC Therapeutics, Inc. $PTCT - MarketBeat
What institutional flow reveals about PTC Therapeutics Inc.Quarterly Trade Summary & Fast Moving Stock Watchlists - Newser
Applying Wyckoff theory to PTC Therapeutics Inc. stockMarket Trend Summary & Fast Gain Swing Alerts - Newser
Published on: 2025-09-03 02:23:46 - Newser
What is PTC Therapeutics Inc.’s valuation compared to sectorMarket Trend Report & Accurate Buy Signal Notifications - khodrobank.com
How cyclical is PTC Therapeutics Inc.’s revenue streamWeekly Profit Recap & Detailed Earnings Play Strategies - khodrobank.com
Earnings visualization tools for PTC Therapeutics Inc.Quarterly Portfolio Report & AI Enhanced Execution Alerts - Newser
Will PTC Therapeutics Inc. benefit from geopolitical trendsQuarterly Performance Summary & Reliable Price Breakout Alerts - khodrobank.com
What is PTC Therapeutics Inc.’s book value per shareJuly 2025 Macro Moves & Free Real-Time Volume Trigger Notifications - khodrobank.com
PTC Therapeutics, Inc. $PTCT Holdings Trimmed by Trexquant Investment LP - MarketBeat
PTC Therapeutics Inc. stock outlook for YEAR2025 Analyst Calls & AI Enhanced Trade Execution Alerts - Newser
PTC Therapeutics Director Allan Jacobson Sells 1667 Shares for $50.15 Each on 08/28/2025. - AInvest
Can PTC Therapeutics Inc. maintain its current growth rateJuly 2025 Decliners & AI Forecast for Swing Trade Picks - khodrobank.com
RareMed Solutions Expands Relationship with PTC Therapeutics - Contract Pharma
RareMed Expands Relationship with PTC Therapeutics for Sephience Therapy Launch - AInvest
RareMed Announces Expansion of Relationship with PTC Therapeutics - PR Newswire
PTC Therapeutics, Inc. $PTCT Holdings Lessened by Armistice Capital LLC - MarketBeat
Is it time to cut losses on PTC Therapeutics Inc.2025 Support & Resistance & Consistent Profit Alerts - Newser
What recovery options are there for PTC Therapeutics Inc.July 2025 Highlights & Consistent Growth Equity Picks - Newser
Smart tools for monitoring PTC Therapeutics Inc.’s price actionTrade Risk Report & Expert Approved Momentum Trade Ideas - Newser
Volatility clustering patterns for PTC Therapeutics Inc.Stop Loss & Weekly Top Stock Performers List - Newser
Finanzdaten der Ptc Therapeutics Inc-Aktie (PTCT)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):